The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The approach -- using a placebo when a "standard-of-care" vaccine already exists -- is contentious within the biomedical ...

BRUSSELS - The World Health Organization's member states on Tuesday adopted a landmark Pandemic Agreement on tackling future ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

The World Health Organization's member countries on Tuesday approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID-19 vaccine boosters.

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults.

Advisers to the US Food and Drug Administration voted on Tuesday to recommend COVID-19 vaccine booster shots for Americans 65 ...